Determinants of the recommended phase 2 dose of molecular targeted agents.

MLA

Hansen, Aaron R., et al. “Determinants of the Recommended Phase 2 Dose of Molecular Targeted Agents.” Cancer, vol. 123, no. 8, Apr. 2017, pp. 1409–15. EBSCOhost, https://doi.org/10.1002/cncr.30579.

APA

Hansen, A. R., Cook, N., Amir, E., Siu, L. L., & Abdul Razak, A. R. (2017). Determinants of the recommended phase 2 dose of molecular targeted agents. Cancer, 123(8), 1409–1415. https://doi.org/10.1002/cncr.30579

Chicago

Hansen, Aaron R, Natalie Cook, Eitan Amir, Lillian L Siu, and Albiruni Ryan Abdul Razak. 2017. “Determinants of the Recommended Phase 2 Dose of Molecular Targeted Agents.” Cancer 123 (8): 1409–15. doi:10.1002/cncr.30579.